Quantcast

Latest lung cancer Stories

2014-10-23 12:29:27

Medicare has an ethical obligation to cover low-dose CT scans NEW YORK, Oct. 23, 2014 /PRNewswire-iReach/ -- Lung Cancer Action Network (LungCAN®) members are encouraging Congress to compel the Centers for Medicare and Medicaid Services (CMS) to cover low-dose CT scans for high-risk seniors. In a recently launched online social media campaign, LungCAN members and their constituents are fighting back with Tweets, Facebook posts, and social ads with a message that is loud and clear:...

2014-10-21 12:29:40

However, Restrictions in Drug Coverage and Molecular Testing Limit Patient Access to Biomarker-Associated Agents, According to Findings from Decision Resources Group BURLINGTON, Mass., Oct. 21, 2014 /PRNewswire/ -- Decision Resources Group finds that the majority of surveyed oncologists in Argentina and Mexico are primarily prescribing biomarker-driven agents for the treatment of HER2-positive breast cancer and EGFR-mutation positive metastatic, non-small-cell lung cancer (NSCLC). However,...

2014-10-21 08:34:05

Patients have immediate access to a blood test for early detection of lung cancer PHOENIX, Oct. 21, 2014 /PRNewswire/ -- Global Cancer Diagnostics Inc. today announced the availability of The Lung Cancer Test(TM) beginning, October 20, 2014. All required Clinical Validation studies are complete with excellent results. The Test detects the presence of the required biomarkers that aid in the early detection of lung cancer. Global Cancer Diagnostics (GCDx) plans to offer this new test...

2014-10-21 08:33:34

-- LUME-COLON 1 will evaluate the efficacy and safety of nintedanib in specific patients with metastatic colorectal cancer (mCRC) whose disease has progressed on previous treatment RIDGEFIELD, Conn., Oct. 21, 2014 /PRNewswire/ -- Boehringer Ingelheim today announced enrollment of the first patient in a new global Phase III study in patients with metastatic colorectal cancer (mCRC). Colorectal cancer is the third most common cancer in the world, with nearly 1.4 million new cases...

2014-10-20 08:33:28

Funds to Support Commercial Expansion in the U.S. and International Launch of the Veran Thoracic Navigation System(TM) ST. LOUIS, Mo., Oct. 20, 2014 /PRNewswire/ -- Veran Medical Technologies, a market leader in thoracic navigation for early detection of lung cancer, announced today the completion of a $12M financing to support the Company's continued commercial expansion in the U.S. and international launch of the Veran Thoracic Navigation System(TM). A strong syndicate of private...

2014-10-15 23:12:34

Veterans of several wars could be at risk due to exposure to asbestos, the New York Law Firm of Rudolph F.X. Migliore, P.C. announces, as recent studies explore new treatment options. New York (PRWEB) October 15, 2014 The Long Island law firm of Rudolph F. X. Migliore, P.C. announces that veterans could be at an increased risk of lung cancer from exposure to asbestos during World War II, the Korean War of the Vietnam War. Working many years in a field that involves being exposed to...

2014-10-14 16:26:37

LONDON, Oct. 14, 2014 /PRNewswire/ -- The BCC Research Tarceva Forecast is a quantitative forecast model in an easily accessible Microsoft Excel spreadsheet, segmented by specific parameters.The introductory sample of the Tarceva Forecast Model was already sent in the update earlier today. I have attached it again for your reference. The model features:- Market demand forecasts for Tarceva annually for the years 2010 to 2030 by volume (number of patients) and value (in U.S. dollars)-...

2014-10-14 08:33:18

SAN RAFAEL, Calif., Oct. 14, 2014 /PRNewswire/ -- Sanovas Inc., a Life Science company accelerating the development and commercialization of next-generation microinvasive diagnostics, devices and drug delivery technologies, announced today that US Patent No. 8,834,544 has issued to the Company. Photo - http://photos.prnewswire.com/prnh/20141013/151744 Logo - http://photos.prnewswire.com/prnh/20141013/151743LOGO The patent, entitled "Photodynamic Therapy for Tumors...

2014-10-10 20:20:38

National Radon Action Week is an important time for homeowners to educate themselves on the dangers of radon. Radon is a problem that affects millions of homes across the country, it has been estimated that 1 out of 15 homes are affected in the United States. This is the time to get informed in order to stay safe and healthy inside your home. LANSING, Mich., Oct. 10, 2014 /PRNewswire/ -- National Radon Action Week is October 20th - 26th for 2014, occurring the 3rd week of October...

2014-10-09 08:27:59

DelMar Pharmaceuticals Presents Data at AACR's New Horizons in Cancer Research Conference in Shanghai, China VANCOUVER, British Columbia, MENLO PARK, Calif. and SHANGHAI, Oct. 9, 2014 /PRNewswire/ -- DelMar Pharmaceuticals, Inc., (OTCQB: DMPI), a clinical-stage oncology company, today announced the presentation of promising new data supporting the activity of its lead drug compound, VAL-083, in the treatment of non-small cell lung cancer (NSCLC) at the AACR's New Horizons in Cancer Research:...


Latest lung cancer Reference Libraries

Clinical Lung Cancer
2012-05-14 11:09:55

Clinical Lung Cancer is a peer-reviewed medical journal published bimonthly by the CIG Media Group. It was established in 1999. As of May 2012, the editor-in-chief is David R. Gandara. Gandara is a member of the Board of Directors of the International Association for the Study of Lung Cancer and the Addario Foundation. He has also served as a member of the Board of Directors of the American Society of Clinical Oncology (ASCO) and as secretary-treasurer. He is furthermore a member of...

More Articles (1 articles) »
Word of the Day
ramage
  • Boughs or branches.
  • Warbling of birds in trees.
Related